Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer

Plasma cell-free tumor DNA, or circulating tumor DNA (ctDNA), from liquid biopsy is a potential source of tumor genetic material, in the absence of tissue biopsy, for EGFR testing. Our validation study reiterates the clinical utility of ctDNA next generation sequencing (NGS) for EGFR mutation testin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Lung Cancer (Auckl)
Hauptverfasser: Veldore, Vidya H, Choughule, Anuradha, Routhu, Tejaswi, Mandloi, Nitin, Noronha, Vanita, Joshi, Amit, Dutt, Amit, Gupta, Ravi, Vedam, Ramprasad, Prabhash, Kumar
Format: Artigo
Sprache:Inglês
Veröffentlicht: Dove Medical Press 2018
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5757203/
https://ncbi.nlm.nih.gov/pubmed/29379323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S147841
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge